Literature DB >> 11708911

Analysis of selective regions in the active sites of human cytochromes P450, 2C8, 2C9, 2C18, and 2C19 homology models using GRID/CPCA.

M Ridderström1, I Zamora, O Fjellström, T B Andersson.   

Abstract

This study demonstrates a selectivity analysis using the GRID/CPCA strategy on four human cytochrome P450 2C homology models (CYP2C8, 2C9, 2C18, and 2C19). Although the four enzymes share more than 80% amino acid sequence identity, the substrate specificity differs. To investigate the selectivity of the enzymes and the amino acids that determine the specificity of each CYP2C enzyme, a selectivity analysis was made using GRID/CPCA. In the GRID calculations 10 probes were used covering hydrophobic, steric, and hydrogen bond acceptor and donor interactions. The selectivity analysis showed that the most important determinants of selectivity among the CYP2C models are the geometrical features of the active sites and the hydrophobic interactions. The selectivity analysis singled out CYP2C8 as the most different of the four CYP2C enzymes with amino acids with distinct properties in positions 114, 205, and 476 (Ser, Phe, and Ile, respectively) compared to the other enzymes. An inverse pharmacophore model for CYP2C9 was constructed from the selective regions, and the model agreed with the docking of diclofenac where the properties of the ligand overlapped with the pharmacophoric points in the model.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11708911     DOI: 10.1021/jm0109107

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  11 in total

1.  New methods in predictive metabolism.

Authors:  Scott Boyer; Ismael Zamora
Journal:  J Comput Aided Mol Des       Date:  2002 May-Jun       Impact factor: 3.686

Review 2.  New methods in predictive metabolism.

Authors:  Scott Boyer; Ismael Zamora
Journal:  Mol Divers       Date:  2002       Impact factor: 2.943

3.  Peroxisome proliferator-activated receptors target family landscape: a chemometrical approach to ligand selectivity based on protein binding site analysis.

Authors:  Bernard Pirard
Journal:  J Comput Aided Mol Des       Date:  2003-11       Impact factor: 3.686

4.  Participation of CYP2C8 and CYP3A4 in the N-demethylation of imatinib in human hepatic microsomes.

Authors:  Noelia Nebot; Severine Crettol; Fabrizio d'Esposito; Bruce Tattam; David E Hibbs; Michael Murray
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

5.  Inhibition of cytochrome p450 enzymes by the e- and z-isomers of norendoxifen.

Authors:  Jinzhong Liu; Peter J Flockhart; Deshun Lu; Wei Lv; Wenjie Jessie Lu; Xu Han; Mark Cushman; David A Flockhart
Journal:  Drug Metab Dispos       Date:  2013-07-03       Impact factor: 3.922

6.  Studies of binding modes of (S)-mephenytoin to wild types and mutants of cytochrome P450 2C19 and 2C9 using homology modeling and computational docking.

Authors:  Akifumi Oda; Noriyuki Yamaotsu; Shuichi Hirono
Journal:  Pharm Res       Date:  2004-12       Impact factor: 4.200

7.  Variability of CYP2C8 Polymorphisms in Three Jordanian Populations: Circassians, Chechens and Jordanian-Arabs.

Authors:  Sara Abudahab; Nancy Hakooz; Nuha Tobeh; Esraa Gogazeh; Munir Gharaibeh; Laith Al-Eitan; Malek Zihlif; Rana Dajani
Journal:  J Immigr Minor Health       Date:  2021-08-26

8.  The role of Ile476 in the structural stability and substrate binding of human cytochrome P450 2C8.

Authors:  Lu Sun; Zhong-Hua Wang; Feng-Yun Ni; Xiang-Shi Tan; Zhong-Xian Huang
Journal:  Protein J       Date:  2010-01       Impact factor: 2.371

9.  Effective virtual screening protocol for CYP2C9 ligands using a screening site constructed from flurbiprofen and S-warfarin pockets.

Authors:  Tímea Polgár; Dóra K Menyhárd; György M Keseru
Journal:  J Comput Aided Mol Des       Date:  2007-10-25       Impact factor: 3.686

10.  Cunninghamella as a microbiological model for metabolism of histamine H(3) receptor antagonist 1-[3-(4-tert-butylphenoxy)propyl]piperidine.

Authors:  Elżbieta Pękala; Paulina Kubowicz; Dorota Łażewska
Journal:  Appl Biochem Biotechnol       Date:  2012-09-16       Impact factor: 2.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.